Stock Information
Solid Biosciences Inc (SLDB)
Ticker Symbol: SLDB
Exchange: NASDAQ
Sector: N/A
Market Cap: $411.93 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.4934
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -73.63%
Latest News
-
Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
Fri, Feb 13, 2026 6:17 PM
-
Solid Biosciences: Positive FDA Meeting For SGT-003 Sets Up Next Milestones
Mon, Feb 9, 2026 6:22 PM
-
Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy
Mon, Feb 9, 2026 1:00 PM
-
Needham Reiterates Buy on Solid Biosciences, Maintains $16 Price Target
Mon, Feb 9, 2026 12:53 PM
-
Solid Biosciences Announces Positive Regulatory Update From Type C Meeting With FDA Supporting Continued Advancement Of SGT-003 As Potential Treatment For Duchenne Muscular Dystrophy
Mon, Feb 9, 2026 9:11 AM
Key Financials
Financial data not available
